← Open Payments lookup

ASHLEY LAY: Open Payments

NPI 1265188940 · SALINAS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,057 in 58 payments from 22 companies in 2025. Trend: 2023 $865 · 2024 $252 · 2025 $2,057

Food & beverage: $1,268Education: $789
CompanyPaymentsAmount
Astellas Pharma US Inc10$527
Janssen Biotech, Inc.12$321
AstraZeneca Pharmaceuticals LP5$214
E.R. Squibb & Sons, L.L.C.2$122
Incyte Corporation2$118
Novartis Pharmaceuticals Corporation3$93
Aveo Pharmaceuticals, Inc.2$93
Takeda Pharmaceuticals U.S.A., Inc.3$86
TAIHO ONCOLOGY, INC.2$62
Karyopharm Therapeutics Inc.2$57

Products named: RYBREVANT, DARZALEX, OPDIVO, FOTIVDA, Enhertu, TAGRISSO, KISQALI, LONSURF.

Industry payments across CA — which companies pay providers there.